Sophiris Bio Overview

  • Year Founded
  • 2002

Year Founded

  • Status
  • Out of Business

  • Employees
  • 6

Employees

  • Latest Deal Type
  • Out of Business

  • Financing Rounds
  • 12

  • Investments
  • 1

Sophiris Bio General Information

Description

Developer of biopharmaceutical therapies intended for the treatment of urological diseases and prostate conditions in the United States. The company develops targeted protein-based therapeutics, including topsalysin for localized prostate treatment, using selective activation mechanisms.

Contact Information

Formerly Known As
SNB Capital, Protox Therapeutics
Ownership Status
Out of Business
Financing Status
Corporation
Corporate Office
  • CA 92037
  • United States
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Former Stock Listing
BFF1
Corporate Office
  • CA 92037
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Sophiris Bio Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Sophiris Bio‘s full profile, request access.

Request a free trial

Sophiris Bio Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of biopharmaceutical therapies intended for the treatment of urological diseases and prostate conditions in th
Drug Discovery
CA
6 As of 2019

San Diego, CA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Sophiris Bio Competitors (1)

One of Sophiris Bio’s competitors is Viking Therapeutics, a Formerly VC-backed company based in San Diego, CA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Viking Therapeutics Formerly VC-backed San Diego, CA
You’re viewing 1 of 1 competitors. Get the full list »

Sophiris Bio Patents

Sophiris Bio Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2017212734-A1 A method for targeted intraprostatic administration of prx302 for treatment of prostate cancer Inactive 27-Jan-2016
CA-3012459-A1 A method for targeted intraprostatic administration of prx302 for treatment of prostate cancer Inactive 27-Jan-2016
EP-3407906-A1 A method for targeted intraprostatic administration of prx302 for treatment of prostate cancer Inactive 27-Jan-2016
EP-3407906-A4 A method for targeted intraprostatic administration of prx302 for treatment of prostate cancer Inactive 27-Jan-2016
WO-2017132610-A1 A method for targeted intraprostatic administration of prx302 for treatment of prostate cancer Inactive 27-Jan-2016 A61K38/17
To view Sophiris Bio’s complete patent history, request access »

Sophiris Bio Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Sophiris Bio Acquisitions (1)

Sophiris Bio’s most recent deal was a Merger/Acquisition with SNB Capital (Special Purpose Acquisition Company). The deal was made on 13-Jul-2004.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
SNB Capital (Special Purpose Acquisition Company) 13-Jul-2004 Merger/Acquisition Special Purpose Acquisition Company (SPAC)
To view Sophiris Bio’s complete acquisitions history, request access »

Sophiris Bio FAQs

  • When was Sophiris Bio founded?

    Sophiris Bio was founded in 2002.

  • Where is Sophiris Bio headquartered?

    Sophiris Bio is headquartered in CA.

  • What is the size of Sophiris Bio?

    Sophiris Bio has 6 total employees.

  • What industry is Sophiris Bio in?

    Sophiris Bio’s primary industry is Drug Discovery.

  • Is Sophiris Bio a private or public company?

    Sophiris Bio is a Private company.

  • What is Sophiris Bio’s current revenue?

    The current revenue for Sophiris Bio is .

  • How much funding has Sophiris Bio raised over time?

    Sophiris Bio has raised $163M.

  • Who are Sophiris Bio’s competitors?

    Viking Therapeutics is a competitor of Sophiris Bio.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process